MSD SVP Deepak Khanna: Taking a Europe-Wide Approach in the Fight Against Cancer
There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to become the region’s leading cause of death without…
Address: Namur Office Park | Avenue des Dessus de Lives, 6 | B-5101 Loyers (Namur)
Tel: +32 81 33 28 50
Web: http://www.investinwallonia.be/?lang=en
Helping foreign investors to successfully set up and integrate their activities as part of the regional economic fabric.
The Foreign Investors division of the Agence Wallonne à l’Exportation et aux Investments étrangers (AWEX) (Walloon Exports and Foreign Investments Agency) is home to a multilingual team of expert consultants who are entirely at your service.
From an initial feasibility study all the way up to signing on the dotted line in concluding the investment, we provide personalised assistance geared to your needs and situation.
If you are a foreign investor looking to develop your activities in Wallonia, you can rest safe in the knowledge that our team of experts is there to assist you every step of the way.
Contact us!
Investor services : the point of single contact for all aspiring foreign investors seeking to set up business in Wallonia.
Our remit is:
to help you in seeking out appropriate sites and premises;to provide assistance with the start-up, development and diversification of your business;
to help you gain access to venture capital;
to provide advice and assistance in attracting suitable human resources;
to help you with setting up training programmes;
to provide assistance in obtaining subsidies from the Regional and European authorities;
to provide legal, tax and logistics support;
There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to become the region’s leading cause of death without…
Joris Van Assche, managing director of the Belgian association for accessible medicines, Medaxes, highlights the need for a stronger policy to create a more positive environment for generic and biosimilar…
Speaking at the 2020 European Cancer Forum in Brussels, MSD’s Deepak Khanna outlines the progress that the company is making at the forefront of oncological innovation, the importance of multi-stakeholder…
After reaching revenues of EUR 2.323 billion in the first six months of 2019, UCB announced on December 18 that it will build an innovative multi-product biological manufacturing facility on…
The second edition of the European Cancer Forum was held in Brussels, Belgium on Tuesday, 29 January 2020. Hosted by MSD in collaboration with the European Cancer Patient Coalition (ECPC),…
Jean-Christophe Tellier became UCB’s CEO on January 1, 2015 only a few years joining the company in 2011. Before taking on the role Tellier held positions as executive VP of…
Annie Hubert, Senior Director, EU Section & Public Policy for the Alliance for Regenerative Medicine (ARM) describes some of the issues that companies in the advanced therapies field are facing…
One of NNE Pharmaplan’s latest exciting news is that last year you established offices to accommodate your existing customers in Belgium. What were the strategic motivations for establishing a presence…
Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout…
Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout…
Mrs van der Kamp, you launched your career as a strategy consultant however, since then you have moved into the pharmaceutical industry by joining Novartis where you quickly worked your…
With an expenditure of more than 10% of GDP on health, Belgium maintains one of the world’s leading healthcare systems. That said, could you please comment on the current state…
See our Cookie Privacy Policy Here
